Explorer les evidences

68,1 %La prévalence de la neuropathie chez les personnes vivant avec le VIH au Kenya était de 68,1 % en 2020.

KenyaVIH/sidaobservé 2020HAL · Unilimdocument de 747 observations

210 000 casesIn 2023, over 210,000 new HIV acquisitions occurred in Kenya, Mozambique, Nigeria, Uganda and Zambia.

Kenya · Mozambique · Nigeria · Ouganda · ZambieVIH/sidaobservé 2023publié 2025Journal of the International AIDS SocietyPubMeddocument de 2 observations

41 %Among 70 transfeminine participants, 28 (41%) were HIV-positive.

KenyaVIH/sidaobservé 2017publié 2021The lancet. HIVPubMeddocument de 14 observations

40,8 %Among 1,500 intervention participants, 250 (40.8%) men were late retesters.

KenyaVIH/sidapublié 2022BMC public healthPubMeddocument de 9 observations

0,66 adjusted_hazard_ratioCompared to the pre-COVID-19 period, the COVID-19 period had lower six-months non-retention with an adjusted hazard ratio of 0.66 (95% CI: 0.58–0.74).

KenyaVIH/sidaobservé April 2020–March 2021 vs. pre-COVID-19publié 2023PloS onePubMeddocument de 7 observations

5,14 relative_riskMothers unaware of their partners’ HIV status had a relative risk of 5.14 for infant HIV positivity at 12 months.

KenyaVIH/sidaobservé 12 monthspublié 2023European Journal of Public HealthOpenAlexdocument de 7 observationsDOI 10.1093/eurpub/ckad160.824

18 %In a competing risk model, viral suppression increased by 18% for each additional year of age among pregnant and postpartum women living with HIV attending a large referral facility in Kenya from 2015 to 2019.

KenyaVIH/sidaobservé 2015 to 2019publié 2022AIDS and behaviorPubMeddocument de 4 observations

1,51 odds_ratioPrincipal component 1 (PC1), comprising VEGF, MIP-1β, VEGF-C and IL-4, was significantly associated with HIV-1 acquisition with an adjusted odds ratio of 1.51 (95% CI: 1.14–2.00) and p=0.004.

KenyaVIH/sidapublié 2023Frontiers in immunologyPubMeddocument de 3 observations

14 mutationsOut of 17 new mutations, 14 resulted in virologic failure.

KenyaVIH/sidapublié 2021The Pan African medical journalPubMeddocument de 3 observations

23 262 patientsA total of 23262 (84.2%) of the 27641 patients eligible for early refill received an extra 3-month supply of antiretrovirals in Kisumu County, Kenya during the coronavirus disease 2019 pandemic.

KenyaVIH/sidapublié 2020AIDS (London, England)PubMeddocument de 2 observations

81 %Among 97 children with HIV on isoniazid preventive therapy, 81% were virally suppressed (<1000 copies/ml).

KenyaVIH/sidaobservé 2019 through 2020publié 2024AIDS (London, England)PubMeddocument de 5 observations

3 self-testsParticipants offered a median of three self-tests to sexual partners.

KenyaVIH/sidapublié 2020Journal of the International AIDS SocietyPubMeddocument de 15 observations

8,3 %Among HIV-infected patients in Central Kenya, those on TB treatment during their last known visit decreased from 8.3% in 2004 to 3.9% in 2014.

Kenyatuberculose · VIH/sidaobservé 2004 to 2014publié 2021BMC infectious diseasesPubMeddocument de 10 observations

74 %Of the 230 participants encouraged to stop PrEP according to strategy recommendations, 170 (74%) did so.

KenyaVIH/sidapublié 2020BMC public healthPubMed

86 %86% of the adolescents and young adults living with HIV were satisfied with the disclosure process.

KenyaVIH/sidaobservé 2019publié 2023Frontiers in public healthPubMeddocument de 18 observations

93 %At baseline, 56 out of 60 participants living with HIV (93%) had initiated antiretroviral therapy.

KenyaVIH/sidapublié 2023BMC health services researchPubMeddocument de 12 observations

-45 USDBetter management was associated with lower unit costs for HIV testing services (HTS) of $-45.

KenyaHIV testing services (HTS) · VIH/sidapublié 2025PloS onePubMeddocument de 8 observations

1 694 individualsAmong children and adolescents living with HIV in central Kenya, 1,694 (35.1%) were enrolled at WHO stage III disease.

KenyaVIH/sidapublié 2022AIDS research and human retrovirusesPubMeddocument de 18 observations

4,58 per_100_PYARA total of 8 cases of HIV infection were observed in 174.5 Person Years at Risk (PYAR), all among MSM, resulting in an HIV incidence of 4.58 cases per 100 PYAR among MSM enrolled in the study.

KenyaVIH/sidapublié 2022BMC public healthPubMeddocument de 11 observations

73 %The proportion of adolescents and young people living with HIV on antiretroviral therapy with unsuppressed viral load who completed three enhanced adherence counselling sessions rose to 73% during the implementation period.

KenyaVIH/sidaobservé from March 2019 to July 2020publié 2022BMJ open qualityPubMeddocument de 8 observations

Malaria co-infection was not associated with worsened leucopenia in people living with HIV.

Kenyaleucopenia · paludisme · VIH/sidapublié 2023International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 8 observations

No vaccine-related serious adverse events were reported in Phase I and IIA HIV vaccine trials enrolling healthy, HIV-seronegative African volunteers.

KenyaVIH/sidaobservé 2001-2007publié 2014Human vaccines & immunotherapeuticseurope_pmcdocument de 10 observationsDOI 10.4161/hv.27559

4 hazard_ratioHaving a nonpaying, regular partner was associated with an increased pregnancy risk with an adjusted hazard ratio of 4.0 among female sex workers living with HIV in Mombasa, Kenya.

KenyaVIH/sidaobservé October 2012-April 2017publié 2020Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 10 observations

2,2 per_100_person_yearsHIV incidence was 2.2 per 100 person-years among African adolescent girls and young women in the POWER study.

KenyaVIH/sidapublié 2022Journal of the International AIDS SocietyPubMeddocument de 12 observations

35 %Tuberculosis/HIV coinfection rate was 35% among the cohort of 291 patients in Vihiga County.

Kenyatuberculose · VIH/sidapublié 2023African health sciencesPubMeddocument de 6 observations